Abstract
Presently, azoles have emerged as excellent antifungal agents. Their broad-spectrum activity and ability to treat superficial as well as invasive infections have gained them incredible repute in antimicrobial therapy. Azoles inhibit the synthesis of ergosterol in fungi, which is important for maintaining the cell wall. This review briefly portrays the relevance of azoles in treating cancer linked fungal infections like candidiasis and aspergillosis. First generation azoles like itraconazole and fluconazole are preferred over other drugs like amphotericin B. Newer azoles (triazoles like voriconazole, posaconazole and ravuconazole) have been synthesized to oust the earlier varieties by being more potent and active against resistant organisms. Patients with lymphoma or leukemia undergoing chemotherapy or stem cell transplantation have weak immune status which makes them susceptible hosts of fungal infections. Azoles are used currently for antitumor therapy because of their specificity towards human cytochrome P-450 dependent enzymes which synthesize cholesterol. This review also attempts to point out how their applications in prostate cancer and breast cancer therapy are indispensable. But along with its advantages, it is necessary to look into the sinister role it plays in creating toxic side effects for patients. Disruption of the endocrine functioning and hepatotoxicity result in manifestations like vomiting, nausea and fatigue. Even though these complications are reversible, the full-fledged practicability of these drugs in cancer treatment is yet to be considered.
Keywords: Aromatase, Aspergillosis, Candidiasis, cancer, lanosterol-14α-demethylase, toxicity, triazoles.
The Natural Products Journal
Title:Emergence of Azole Therapy for Cancer Associated Fungal Infections and Their Potential Human Toxicity
Volume: 4 Issue: 2
Author(s): Lesley R. Varughese, Sneha Choubey, Mukesh Yadav and Vikas Beniwal
Affiliation:
Keywords: Aromatase, Aspergillosis, Candidiasis, cancer, lanosterol-14α-demethylase, toxicity, triazoles.
Abstract: Presently, azoles have emerged as excellent antifungal agents. Their broad-spectrum activity and ability to treat superficial as well as invasive infections have gained them incredible repute in antimicrobial therapy. Azoles inhibit the synthesis of ergosterol in fungi, which is important for maintaining the cell wall. This review briefly portrays the relevance of azoles in treating cancer linked fungal infections like candidiasis and aspergillosis. First generation azoles like itraconazole and fluconazole are preferred over other drugs like amphotericin B. Newer azoles (triazoles like voriconazole, posaconazole and ravuconazole) have been synthesized to oust the earlier varieties by being more potent and active against resistant organisms. Patients with lymphoma or leukemia undergoing chemotherapy or stem cell transplantation have weak immune status which makes them susceptible hosts of fungal infections. Azoles are used currently for antitumor therapy because of their specificity towards human cytochrome P-450 dependent enzymes which synthesize cholesterol. This review also attempts to point out how their applications in prostate cancer and breast cancer therapy are indispensable. But along with its advantages, it is necessary to look into the sinister role it plays in creating toxic side effects for patients. Disruption of the endocrine functioning and hepatotoxicity result in manifestations like vomiting, nausea and fatigue. Even though these complications are reversible, the full-fledged practicability of these drugs in cancer treatment is yet to be considered.
Export Options
About this article
Cite this article as:
Varughese R. Lesley, Choubey Sneha, Yadav Mukesh and Beniwal Vikas, Emergence of Azole Therapy for Cancer Associated Fungal Infections and Their Potential Human Toxicity, The Natural Products Journal 2014; 4 (2) . https://dx.doi.org/10.2174/221031550402141009100751
DOI https://dx.doi.org/10.2174/221031550402141009100751 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors
Current Medicinal Chemistry Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design Stem Cell Pharmacogenomics
Current Topics in Medicinal Chemistry Human Cancer Cell Line Based Approach of 1,3,4-thiadiazole and its Fused Ring: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds STAT3 and Its Phosphorylation are Involved in HIV-1 Tat-Induced Transactivation of Glial Fibrillary Acidic Protein
Current HIV Research Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Current Molecular Pharmacology Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Is there a Role for Epigenetic Enhancement of Immunomodulatory Approaches to Cancer Treatment?
Current Cancer Drug Targets Incidentally Detected Increased FDG Uptake in Bowel and its Correlation with Hystopathological Data: Our Experience in a Case Series Study
Current Radiopharmaceuticals Heterocyclic Analogues as Kinase Inhibitors: A Focus Review
Current Topics in Medicinal Chemistry MicroRNA-21 as Therapeutic Target in Cancer and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Development of Peptide and Protein Based Radiopharmaceuticals
Current Pharmaceutical Design From the Sea to Anticancer Therapy
Current Medicinal Chemistry Laccases in Pharmaceutical Chemistry: A Comprehensive Appraisal
Mini-Reviews in Organic Chemistry Circulating Nucleic Acids in Plasma and Serum: Roles in Diagnosis and Prognosis in Diabetes and Cancer
Infectious Disorders - Drug Targets Promising Targets in Anti-cancer Drug Development: Recent Updates
Current Medicinal Chemistry The Effects of All-Trans-Retinoic Acid on Cell Cycle and Alkaline Phosphatase Activity in Pancreatic Cancer Cells
Medicinal Chemistry Synthetic and Biological Aspects of Thiadiazoles and their Condensed Derivatives: An Overview
Current Topics in Medicinal Chemistry